SKI Market

A+| A| A-|

Indian Indices

Sensex

76,808.48 544.15
( 0.71%)

Global Indices

Nasdaq

51,705.57 482.31
(0.94%)

Dow Jones

7,575.20 122.74
(1.65%)

Hang Seng

69,393.70 76.20
(0.11%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

94.92 -0.57
(-0.60%)

EUR-INR

109.83 -0.42
(-0.38%)

GBP-INR

127.25 -0.49
(-0.38%)

JPY-INR

0.59 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

540596

INE406M01024

230.6075957

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ERIS

75.59

19200.58

EPS(TTM)

Face Value()

Div & Yield %

18.33

0.52

Back

genpharmasec limited

Board of Timken India recommends final dividend

May 19,2026

Timken India announced that the Board of Directors of the Company at its meeting held on 18 May 2026, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

76,808.48 544.15 ( 0.71%)

51,705.57 482.31 (0.94%)

7,575.20 122.74 (1.65%)

69,393.70 76.20 (0.11%)

10,435.69 -36.03 (-0.34%)

94.92 -0.57 (-0.60%)

109.83 -0.42 (-0.38%)

127.25 -0.49 (-0.38%)

0.59 0.00 (-0.48%)